Irreversible Electroporation Versus Standard Medication for Benign Prostatic Obstruction
Status:
Unknown status
Trial end date:
2019-05-30
Target enrollment:
Participant gender:
Summary
Irreversible electroporation (IRE) is a novel ablation modality using electric pulses to
create nanoscale defects in the cell membrane. It has been verified to be safe on the
treatment of prostate, lung, liver and kidney masses. The present is a randomized, controlled
trial, with a main purpose of looking into the safety and feasibility of irreversible
electroporation for patients with benign prostatic obstruction.